Enhanced Recovery in Gynecologic Oncology Surgery-State of the Science

Gregg Nelson
DOI: https://doi.org/10.1007/s11912-023-01442-0
Abstract:Purposeof review: The purpose of this review is to describe the state of the science of enhanced recovery after surgery (ERAS) in gynecologic oncology. Recent findings: Over the last 5 years, there is mounting evidence supporting ERAS in gynecologic oncology surgery. Despite this, surveys have found suboptimal uptake of ERAS, and stakeholders have highlighted the difficulty of ERAS implementation as a major barrier. To address this, the core components required for a successful ERAS implementation program (protocol, ERAS team, audit system) are reviewed. ERAS developments specific to gynecologic oncology are also discussed, including same-day discharge initiatives for minimally invasive surgery, implications of telemedicine, and methods to increase uptake of ERAS in low- and middle-income countries. ERAS is a surgical quality improvement program with strong evidence supporting its effectiveness in gynecologic oncology. Efforts are required to address ERAS implementation barriers to increase uptake globally, especially in low-income settings.
What problem does this paper attempt to address?